Newsroom | 94763 results

DEERFIELD, Ill. & BARCELONA, Spain--(BUSINESS WIRE)--TerSera Therapeutics LLC today announced that it has completed the previously announced sale of its Infusion Specialty Therapies Business Unit (IST), including two specialty medications, Prialt® (ziconotide intrathecal infusion) and Quzyttir® (cetirizine hydrochloride injection) to ESTEVE. Effective today, under the terms of the transaction, ESTEVE fully owns Prialt® and Quzyttir®. Perella Weinberg Partners acted as the financial advisor to E...

BIRMINGHAM, Ala.--(BUSINESS WIRE)--American Family Care Launches Medically Supervised Weight Management Program at Select Urgent Care Locations...

WHIPPANY, N.J.--(BUSINESS WIRE)--ConnectiveRx, a leading provider of technology-enabled patient support and access solutions for specialty and branded medications, today highlighted the scale and precision of its clinically integrated provider engagement network, spanning the full prescribing landscape – from the nation's leading health system EHRs to the outpatient and specialty settings where care is continuously delivered. ConnectiveRx's network reaches more than 1.2 million providers inside...

NEW YORK--(BUSINESS WIRE)--Wisp, the largest women’s telehealth company in the U.S., today announced its expansion into clinician-guided longevity care with the launch of its new Longevity and Healthy Aging category. The initial offering features five science-backed treatments - glutathione (nasal spray and injection), NAD+ (nasal spray and injection), and low-dose naltrexone (LDN) - which work to optimize your biology by fueling cellular energy and repair and recalibrate the immune system. The...

BOSTON--(BUSINESS WIRE)--Odyssey Therapeutics, Inc., a clinical-stage biopharmaceutical company seeking to transform the standard of care for patients suffering from autoimmune and inflammatory diseases by developing medicines that are designed to precisely target disease pathology, today announced the appointment of H. Martin Seidel, Ph.D., to its Scientific Advisory Board. Dr. Seidel is a highly accomplished drug discovery and development leader with decades of experience spanning biotechnolo...

AUSTIN, Texas--(BUSINESS WIRE)--Rugiet, a men’s health company, today announced the launch of its testosterone replacement therapy (TRT), marking a significant expansion beyond its flagship erectile dysfunction treatments. The company, which surpassed $100 million in revenue in 2025, also introduced a new brand identity with the launch, signaling its evolution into a broader performance-driven healthcare company for men. The therapy options include enclomiphene as well as oral, injectable, and...

LOS ANGELES--(BUSINESS WIRE)--Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announced the launch of Niagen® Skincare Innovation Lab, a new product innovation platform designed to translate the Company’s leadership in NAD+ science into category-defining skincare. Debuting under the platform is Niagen NanoCloud™, a limited-release, dermatologist-tested topical skincare product powered by...

GAITHERSBURG, Md.--(BUSINESS WIRE)--Announcing GeneDx's new genetic testing program with Zevra Therapeutics to support patients with suspected Niemann–Pick disease type C (NPC)....

VANCOUVER, British Columbia & GRAPEVINE, Texas--(BUSINESS WIRE)--Alpha Cognition Inc. (Nasdaq: ACOG) (“Alpha Cognition” or the “Company”), a commercial-stage biopharmaceutical company focused on developing therapies for neurodegenerative diseases, today announced it will present new clinical data on ZUNVEYL at the American Association of Geriatric Psychiatrists (AAGP), taking place April 16-20, 2026 and the Neuroscience Education Institute (NEI) Spring Congress, taking place May 1-3, 2026. The...

WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca and Joshua Jackson have teamed up as part of a national public health campaign designed to encourage fans to Get Body Checked Against Cancer and be proactive in speaking with their doctor. Joshua Jackson brings a unique cultural relevance to the initiative, resonating with a generation that grew up watching him on screen and is now entering a life stage where conversations about cancer risk and screenings become increasingly important. To help brin...